Posted by Michael Wonder on 25 Oct 2022
A perspective on life cycle health technology assessment and real world evidence for precision oncology in Canada
25 October 2022 - Health technology assessment can be used to make healthcare systems more equitable and efficient. Advances in precision oncology are challenging conventional thinking about health technology assessment.
Precision oncology advances are rapid, involve small patient groups, and are frequently evaluated without a randomised comparison group.
In light of these challenges, mechanisms to manage precision oncology uncertainties are critical.
